Precision nanomedicines for prostate cancer

被引：7
作者：
Cifuentes-Rius, Anna [1 ,2 ]
Butler, Lisa M. [3 ,4 ,5 ]
Voelcker, Nicolas H. [1 ,2 ,5 ]
机构：
[1] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, Parkville Campus,381 Royal Parade, Parkville, Vic 3052, Australia
[2] Victorian Node Australian Natl Fabricat Facil, Melbourne Ctr Nanofabricat, 151 Wellington Rd, Clayton, Vic 3168, Australia
[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5005, Australia
[4] Univ Adelaide, Freemasons Fdn, Ctr Mens Hlth, Adelaide, SA 5005, Australia
[5] South Australian Hlth & Med Res Inst, Adelaide, SA 5001, Australia
来源：
NANOMEDICINE | 2018年 / 13卷 / 08期
基金：
澳大利亚研究理事会; 英国医学研究理事会;
关键词：
biomarkers; nanomedicine; nanotechnology; precision medicine; prostate cancer; IN-VIVO; HYPOXIA; NANOPARTICLES; DELIVERY; THERAPY; BIOMARKERS;
D O I：
10.2217/nnm-2018-0034
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：803 / 807
页数：5
相关论文
共 50 条
[31]   Nanoparticle therapeutics for prostate cancer treatment [J].
Sanna, Vanna ;
Sechi, Mario .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2012, 8 :S31-S36
[32]   Nanoparticle therapeutics for prostate cancer treatment [J].
Sanna, Vanna ;
Sechi, Mario .
MATURITAS, 2012, 73 (01) :27-32
[33]   The Value of Phenotypic Precision Medicine in Prostate Cancer [J].
Hawkey, Nathan M. ;
Broderick, Amanda ;
George, Daniel J. ;
Sartor, Oliver ;
Armstrong, Andrew J. .
ONCOLOGIST, 2023, 28 (02) :93-104
[34]   Novel nanomedicines to overcome cancer multidrug resistance [J].
Su, Zhenwei ;
Dong, Shaowei ;
Zhao, Shan-Chao ;
Liu, Kaisheng ;
Tan, Yao ;
Jiang, Xingyu ;
Assaraf, Yehuda G. ;
Qin, Bo ;
Chen, Zhe-Sheng ;
Zou, Chang .
DRUG RESISTANCE UPDATES, 2021, 58
[35]   Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy [J].
Guo, Yixuan ;
Liu, Yu ;
Wu, Wei ;
Ling, Daishun ;
Zhang, Qiao ;
Zhao, Peng ;
Hu, Xi .
BIOMATERIALS, 2021, 276
[36]   Precision oncology: transforming cancer care through personalized medicine [J].
Rituraj, Rashmi Saxena ;
Pal, Rashmi Saxena ;
Wahlang, Jenny ;
Pal, Yogendra ;
Chaitanya, M. V. N. L. ;
Saxena, Sumedha .
MEDICAL ONCOLOGY, 2025, 42 (07)
[37]   Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics [J].
Adamaki, Maria ;
Zoumpourlis, Vassilios .
PHARMACOLOGY & THERAPEUTICS, 2021, 228
[38]   Extracellular vesicles for precision medicine in prostate cancer-Is it ready for clinical translation? [J].
Robinson, Harley ;
Roberts, Matthew J. ;
Gardiner, Robert A. ;
Hill, Michelle M. .
SEMINARS IN CANCER BIOLOGY, 2023, 89 :18-29
[39]   Precision medicine for prostate cancer [J].
Galazi, Myria ;
Rodriguez-Vida, Alejo ;
Ng, Tony ;
Mason, Malcolm ;
Chowdhury, Simon .
EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (11) :1305-1315
[40]   A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines [J].
Tang, Jun ;
Perez-Medina, Carlos ;
Zhao, Yiming ;
Sadique, Ahmad ;
Mulder, Willem J. M. ;
Reiner, Thomas .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2017, (121)
12345